UpdatesGeneral Updates
RPG Life Sciences' subsidiary RPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business for up to ₹135 Cr cash.
RPG Life Sciences LimitedRPGLIFE · Filed with the exchange
The acquired unit generated ~₹19 Cr revenue in FY26, including manufacturing, R&D, and 29 API molecules, significantly expanding RPG Life's API portfolio.
No comments yet. Be the first.